The University of Pittsburgh Department of Immunology is delighted to announce three open faculty positions: one at Full/Associate Professor (tenured) and two at Assistant Professor (tenure stream). The Department of Immunology at the University of Pittsburgh School of Medicine is expanding its primary faculty base and invites applicants focused on [READ MORE]
CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus | GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study (GRACE) | Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease (GPAD-3) [READ MORE]
Meet Laura Mackay, Ph.D., Professor at The University of Melbourne and Immunology Theme Lead at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. She completed her Ph.D. in 2009 under the supervision of Professor Alan Rickinson at The University of Birmingham (UK), and postdoctoral training (2009-2015) with Professor Francis Carbone at The University of Melbourne. [READ MORE]
Contributed by Alok Pandey, Ph.D., VP Biomarker & Translational Science, PBL Assay Science When it comes to ELISA kits used for the detection of protein biomarkers, one observation we have made at PBL Assay Science—over and over again—is that not all assays are created equal. From our 30+ years of [READ MORE]
We are excited to recognize two historic milestones that resonate deeply with the International Cytokine and Interferon Society: the 50th anniversary of the term “cytokine” and the 70th anniversary of the introduction of “Interferons.” Contributed by Valeriya Smaliy and Susan Carpenter, Ph.D., University of California at Santa Cruz It was [READ MORE]
Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections | Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma | Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma [READ MORE]
My research interests include understanding the opposing challenges faced by the immune system in response to micro- vs. macro- parasites and is studying the relationship between type 2 cytokines and IL-17 … particularly the evolutionary relationship between type 2 immunity, parasite control and tissue repair and is currently investigating how [READ MORE]
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT | MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera (MITHRIDATE) | Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression (IPOS) [READ MORE]
Congratulations to the newly-elected officers of the ICIS! Several are returning members, while others are joining the board for the first time. It is great to see so many people willing to give generously of their time and “sweat equity” (to adopt a turn of phrase from former ICIS President [READ MORE]
ICIS Council member, Carla Rothlin, Ph.D., recently interviewed Yale University’s Day of Immunology co-founders Dr. Lindsey Hughes, Sarah Ohashi and Sasha Tabachnikova. The following is a lightly edited summary of their conversation. What is Day of Immunology? Day of Immunology is an annual outreach event designed to introduce high school [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
